Latest News
May 16, 2018

On May 16, 2018, Mylan N.V. and Mylan Inc., an indirect wholly owned subsidiary of Mylan N.V., delivered notices to The Bank of New York Mellon, as...

May 14, 2018

Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) and West Virginia University (WVU) today announced a 10-year collaboration, supported by a $5 million charitable contribution from Mylan, to...

May 9, 2018

On May 9, 2018, the U.S. Food and Drug Administration (FDA) posted a supply notification about EpiPen® (epinephrine injection, USP) 0.3 mg and EpiPen Jr® (epinephrine injection, USP) 0.15 mg...

May 9, 2018

Mylan N.V. (NASDAQ: MYL) today announced its financial results for the three months ended March 31, 2018. First Quarter 2018 Financial Highlights Total revenues of $2.68 billion, down 1% compared...

May 2, 2018

Global pharmaceutical company Mylan N.V. (NASDAQ: MYL) today announced that it will release its first quarter 2018 financial results, on Wed., May 9, before the open of the U.S. financial markets....

View More


Search News Releases

Contact Mylan Communications

Global Communications 
724.514.1968
[email protected]

Stay Connected